Innovative Microbiome Focus Biohm Technologies specializes in targeted microbiome products that leverage comprehensive datasets of both bacterial and fungal gut populations, enabling the creation of highly specialized and clinically validated ingredients such as Mycohsa. This unique focus presents opportunities to collaborate with wellness brands seeking science-backed gut health solutions.

Recent Funding and R&D Investment The company has secured $4.5 million in recent funding and appointed a new Vice President of Science & Technology, indicating a commitment to expanding research capabilities and product development. Sales teams can target partners interested in innovative microbiome products backed by ongoing scientific advancements.

Expanding Technological Capabilities Biohm is actively developing AI technology through collaboration with Virginia Tech, enhancing its product innovation pipeline. This strategic move opens doors to partners interested in cutting-edge data-driven supplements and personalized health solutions.

Market Engagement Participation in industry events like SupplySide Connect and Expo West demonstrates active market engagement and branding. Establishing connections at these events can facilitate partnerships with distributors, ingredient buyers, and health brands looking for novel, scientifically validated probiotics.

Flexible Product Offerings With offerings including microbiome testing kits and private label solutions for wellness brands, Biohm connects with companies seeking customizable and innovative gut health products. These avenues represent direct sales opportunities for partners aiming to diversify their microbiome-related product lines.